FCAG
IRWD icon

First Capital Advisors Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

First Capital Advisors Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,464
Closed -$45K – 455
2018
Q1 		$45K Buy
+3,464
New +$43.2K 0.03% 285

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Capital Advisors Group's IRWD Position: Q2 2018 in Review

First Capital Advisors Group sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2018, closing a stake of 3,464 shares — an estimated $45K sold.

First Capital Advisors Group first reported a position in IRWD in Q1 2018 and held it in 1 quarter. The position peaked at $45K in Q1 2018. 148 funds tracked by Wall St. Rank hold IRWD as of Q2 2018.

  • First Capital Advisors Group reported no remaining Ironwood Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • First Capital Advisors Group sold 3,464 Ironwood Pharmaceuticals shares in Q2 2018, an estimated $45K.
  • First Capital Advisors Group first reported a position in Ironwood Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • First Capital Advisors Group's Ironwood Pharmaceuticals position peaked at $45K in Q1 2018.
  • 148 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2018.

Based on First Capital Advisors Group's 13F filing for Q2 2018, filed 30 Jul 2018.